MEKanistic Therapeutics

Private

Minneapolis, MinnesotaHealthcare & Life Scienceshttps://mekanistic.com/

Last Round

Grant

Aug 1, 2023

Total Funding Raised

$914,319

Company Overview

MEKanistic Therapeutics is a biotechnology company that develops innovative kinase inhibitors for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Application

Keywords

dual inhibitorkinase inhibitorstherapeutic resistanceclinical-stage biotechcomputational drug designsolid tumorssmall molecule drugprecision medicineEGFR inhibitorPI3K inhibitorAI drug discoverydrug discoveryoral therapyCNS cancersglioblastomaNational Cancer InstituteNCISmall Business Innovation ResearchSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MEKanistic Therapeutics Comparables

Compare MEKanistic Therapeutics with similar companies based on industry and business-model similarity.

MEKanistic Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
OnKure Therapeutics	77%
BlossomHill Therapeutics	71%
ORIC Pharmaceuticals	66%

View all Comparables

MEKanistic Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Aug 1, 2023
VC Round	Jul 25, 2022
Grant	Feb 15, 2018
Grant	Apr 20, 2017
Grant	Feb 1, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Danny Cunagin

Chief Executive Officer

Executive Team

MEKanistic Therapeutics Investors

Notable investors and investment history

MEKanistic Therapeutics investors
Investor	Rounds
National Cancer Institute	Grant
NIH RADx	Grant
Invenshure	VC Round

View all Investors

MEKanistic Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MEKanistic Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MEKanistic Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinneapolis, Minnesota

Employee Range8

Year Founded2015

Last FundingAug 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.